Pharmaceuticals APAC News & Press Release Distribution

Pharmaceuticals

All
Global

Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific Sessions

SAN FRANCISCO and SUZHOU, China, June 12, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...

2024-06-12 08:00 4709

Last patient in: Laminar Pharmaceuticals S.A. completes recruitment for CLINGLIO, the phase 2b/3 Clinical Trial of idroxioleic acid (LAM561) in combination with RT and TMZ for adults with newly diagnosed glioblastoma

140 patients have been recruited at sites in Spain, Italy, France and United Kingdom. The open readout of the trial is expected by late 2024. Laminar aims to submit regulatory filings or conditional marketing authorization by early 2025. PALMA DE MALLORCA, Spain, June 12, 2024 /PRNewswire/ -- Lam...

2024-06-12 02:15 2781

Chengdu's influence being felt across the world

CHENGDU, China, June 11, 2024 /PRNewswire/ -- Openness is a defining characteristic of contemporaryChina. In recent years, Chengdu, capital of Sichuan province, has used its location as a key hub in the Belt and Road Initiative and as a starting point of the ancient Southern Silk Road. By deepen...

2024-06-11 16:44 12131

Chengdu's influence being felt across the world

Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient GIST Approved by the China CDE

SUZHOU, China, and ROCKVILLE, Md., June 11, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the Center for Drug Evaluation (CDE) ofChina'...

2024-06-11 11:25 4746

Element Six and Orbray partner to deliver the world's highest quality wafer-scale single crystal synthetic diamond

GRESHAM, Ore. and TOKYO, June 11, 2024 /PRNewswire/ -- Element Six (E6) and Orbray , both world leaders in high-performing advanced materials, today announced a strategic collaboration to deliver the world's highest quality wafer-scale single crystal ...

2024-06-11 08:00 6106

Octapharma's continuing dedication to improving the lives of people with rare bleeding disorders to be showcased at ISTH 2024

* Octapharma to present new clinical and scientific findings for wilate® and Nuwiq® at the upcoming ISTH 2024 Congress * New data and clinical study developments to be showcased in seven oral presentations, two posters and two Supported Symposia LACHEN, Switzerland, June 10, 2024 /PRNewswire/...

2024-06-10 21:09 4255

ILJIN SNT Co., Ltd. Announces Its Intention to Vote Against Aurinia Pharmaceuticals's Revised Equity Incentive Plan Proposal

SEOUL, South Korea, June 7, 2024 /PRNewswire/ -- Dear Fellow Shareholders, ILJIN SNT Co., Ltd. ("ILJIN") is a long-standing investor of Aurinia Pharmaceuticals Inc. ("Aurinia" or the "Company"), and, together with its affiliates, currently holds more than 5% of Aurinia's common stock. As one of...

2024-06-07 23:49 6495

IONETIX Produces First Batch of Actinium-225

LANSING, Mich., June 7, 2024 /PRNewswire/ -- IONETIX, a leading cyclotron technology innovator, isotope producer, and radiopharmaceutical manufacturer, announced today the successful production of Actinium-225 ("Ac-225") at its isotope manufacturing facility located inLansing, Michigan. This fir...

2024-06-07 20:27 2647

Brii Bio Presents New Data from Its Ongoing Phase 2 Chronic Hepatitis B Trials at EASL™ Congress 2024

New translational data demonstrate that BRII-179-induced immune responses are associated with high HBsAg reduction in a subset of participants with chronic HBV infection BRII-179 as add-on therapy induces functional antibody responses and contributes toimproved sustained HBsAg loss in PEG-IFNa-t...

2024-06-07 19:00 4679

Clinical Data of First-in-class HBV-specificTCR T Cell Therapy (SCG101) Presented at ESAL Congress Showing Improved Overall Survival in HBV-related Hepatocellular Carcinoma

SINGAPORE, June 7, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, announced that clinical data from its first-in-class autologous hepatitis B virus (HBV)-specific...

2024-06-07 16:51 3908

MLB Announces IND Approval by US FDA to Initiate Phase 1 Trial of TML-6, a New Era Multi-Target Drug for the Treatment of Alzheimer's Disease

TAINAN, June 7, 2024 /PRNewswire/ -- MLB (Merry Life Biomedical Company, Ltd., Taiwan: https://www.tmlbio.com/ ), a biomedical company, announced that the U.S. Food and Drug Administration (FDA) has approved IND application forTML-6, an novel drug to treat Alzheimer's dis...

2024-06-07 15:00 3274

MLB Announces IND Approval by US FDA to Initiate Phase 1 Trial of TML-6, a New Era Multi-Target Drug for the Treatment of Alzheimer's Disease

NDA for Luye Pharma's Rivastigmine Twice Weekly Transdermal Patch Filed in Japan for Treating Alzheimer's Dementia

TOKYO, June 6, 2024 /PRNewswire/ -- Luye Pharma Group announced that its partner Towa Pharmaceutical Co., Ltd. (Towa) has filed a New Drug Application (NDA) to the Ministry of Health, Labour and Welfare (MHLW) inJapan for the Rivastigmine Twice Weekly Transdermal Patch for treating mild to modera...

2024-06-06 17:33 4960

Alphamab Oncology Collaborated with ArriVent in relation to the Research, Development and Commercialization of ADC Products

SUZHOU, China, June 6, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Alphamab"), a wholly-owned subsidiary of the Company, entered into a research and collaboration agreement (the "Collaboration Agreement") with ArriVen...

2024-06-06 10:21 3507

RemeGen Showcases Research Results at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting, Highlighting Its Prolific Innovation in Global Cancer Treatment

YANTAI, China, June 5, 2024 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, showcased its innovation in the field of global cancer treatment at the American Society of Clinical Oncology Annu...

2024-06-05 21:42 3672

Sunway Medical Centre retains Malaysia's top spot in Paediatrics, according to latest Newsweek rankings

The hospital is also ranked highly in the areas of Oncology, Neurology, Neurosurgery, Cardiology, and Cardiac Surgery. SUNWAY CITY, Malaysia, June 5, 2024 /PRNewswire/ -- Sunway Medical Centre (SMC), Sunway City, the flagship quaternary hospital under the Sunway Healthcare Group, retained its to...

2024-06-05 20:00 4360

Sunway Medical Centre retains Malaysia's top spot in Paediatrics, according to latest Newsweek rankings

Pierre Fabre Laboratories Announce IND Filing for PFL-002/VERT-002, a Potential Treatment for Patients with Solid Tumors, Including Non-Small Cell Lung Cancer with MET Alterations

CASTRES, France, June 5, 2024 /PRNewswire/ -- Pierre Fabre Laboratories today announced the filing of an investigational new drug ("IND") application to the U.S. Food and Drug Administration ("FDA") to initiate a first-in-human (FIH) Phase I/II clinical trial with PFL-002/VERT-002 for solid tumor...

2024-06-05 15:15 3333

ASG Pioneers Development of novel inhaled drugs and Accelerates R&D Progress

TAIPEI, June 5, 2024 /PRNewswire/ – Asia Scientific Global (ASG), a leader in the research and development of novel inhaled drugs, has set up a laboratory in Taiwan, and plans to establish a second facility in Singapore later this year. This new lab will focus on developing 505(b)2 new dosage form...

2024-06-05 12:30 2463

Dalton Pharma Services Invests in Robotic Aseptic Powder Fill-Finish Line from 3P innovation

TORONTO, June 5, 2024 /PRNewswire/ -- Pharmaceutical manufacturing company, Dalton Pharma Services (a Seikagaku Group company), has recently commissioned 3P innovation (Warwick, UK) to design and construct a fully automated state-of-the-art high-speed aseptic powder filling line to expedite the ...

2024-06-05 10:00 2569

Dalton Pharma Services Invests in Robotic Aseptic Powder Fill-Finish Line from 3P innovation

RemeGen Reports Proof-of-Concept Phase I/II Clinical Study Results for Self-Developed, Potential First-in-Class Antibody-Drug Conjugate RC88

YANTAI, China, June 4, 2024 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, presented the results of the first-in-human, single-arm, open-label, multi-center Phase I/II study evaluating RC8...

2024-06-04 09:38 2853

Alphamab Oncology Presented Chinese Clinical Data of Anti-HER2 Bispecific ADC JSKN003 for the First Time at the 2024 ASCO Annual Meeting

* Results from the phase I part of JSKN003-102 was reported at this ASCO Annual Meeting. * JSKN003 exhibited a favorable tolerability and manageable safety profile in heavily pretreated patients with advanced/metastatic solid tumors and demonstrated encouraging antitumor activity during dose ...

2024-06-03 10:17 2880

1 ... 72 73 747576 77 78 ... 184